AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers
Advanced Search

Session Details

Corporate Exhibits

[B1]Corporate Exhibits

Mon. Mar 17, 2025 2:00 PM - 5:00 PM JST
Mon. Mar 17, 2025 5:00 AM - 8:00 AM UTC
Lobby(B1)

[B1-01T]Immunogenicity in mice after percutaneous vaccination with HA microneedle array patch vaccine

Masaki Ishibashi1, *Junichi Hinagata1, Hidetoshi Hamamoto1 (1. MedRx Co., Ltd. (Japan))
Comment()

[B1-02T]Development of Vaccines using a Needle-free Intraepidermal Administration Device

*Hirotoshi Adachi1,2, Uros Kascak1 (1. PassPort Technologies, Inc. (United States of America), 2. PassPort Technologies Japan, Inc. (Japan))
Comment()

[B1-03T]Formulation Development of Intranazsal Vaccine and design of spray device for Intranasal Vaccine

Takayuki Nakamura1, *Yuki Katagiri1, Yasuyuki Shiraishi1, Takashi Kamishita2, Toshiaki Takagi2, Natsumi Kodake2, Takashi Miyazaki2 (1. TaiseiKako Co,.Ltd (Japan), 2. TOKO YAKUHINKOGYO CO.,LTD. (Japan))
Comment()

[B1-04T]Hight performance innovative nasal spray device.

*Yuichi Yoshimura1 (1. Nipro Corporation (Japan))
Comment()

[B1-05T]The strategy to achieve high efficacy and safety in mRNA therapeutics

*Tetsuo Yoshida1,2, Rena Akahori2,3, Akiko Yanagiya2, Naoki Matsumoto2, Daichi Matsuura2, Hayato Sato2, Hiroaki Murakami2, Tomohiro Sawadaishi2, Yanwen Feng2, Jun Nihira2, Satoshi Abe2, Kazuyuki Nakashima2 (1. Axcelead, Inc. (Japan), 2. ARCALIS, Inc. (Japan), 3. Hitachi, Ltd. (Japan))
Comment()

[B1-06T]Autonomous Optimization of Vaccine Development Processes: from Patient Administration Schedule to Manufacturing Efficiency.

*Taku Tsuzuki1, Tsuyoshi Tatsukawa1, Yosuke Ozawa2 (1. Epistra Inc. / cSIMVa Chiba University (Japan), 2. Epistra Inc. (Japan))
Comment()

[B1-07]THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY
(BIKEN Foundation)

*Suni LEE1 (1. THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY (BIKEN Foundation) (Japan))
Comment()

[B1-08]Development of the rapid immunochromatographic test kit "ADTest®" and future infectious disease testing

*Yuichi Kida1, Kaoru Kobayashi1, Kenta Fukuda1, Nobiko Takayama1, Takateru Nozaki1, Misako Iwai1, Kaoru Kobayashi1, Katsuyoshi Takayama1 (1. ADTEC Co.,LTD. (Japan))
Comment()

[B1-09]Cytiva's solution in vaccine manufacturing

masahiro oda1, *PeiQing Zhang1 (1. Global Life Science Technologies Japan (Cytiva) (Japan))
Comment()
Back to Category List